±¬ÁϳԹÏÍø

• Senior Research Fellowship, Central Council for Research on Unani Medicine, Government of India. (1998)
• Senior Research Fellowship, Council for Scientific and Industrial Research, New Delhi, Ministry of Health and Welfare, Government of India. (2000)
• Investigator Award, Santa Cruz Biotechnology. (2012)
• Outstanding Researcher Award, Asia International Research Award Tamil Nadu. (2023)

1. NIH/SC1 GM140982-01 (40% Effort)

Title: Targeting ribosome biogenesis and desmoplastic tumor microenvironment for the treatment of advanced pancreatic cancer

Role: Principal Investigator:

Total costs: $1.45 million

Grant Period: Sept. 1, 2021-March 31, 2026

2. CPRIT Pilot Study Award 2023 (10% Effort)

Award Mechanism: TRECPSA

Title: Role of transcription factor UBTF in pancreatic cancer

Role: Principal Investigator:

Total costs: $200,000

Grant Period: Aug. 1, 2023-Aug. 31, 2025

3. NIH/RO1 CA210192-01

Title: Targeted nanotherapy for pancreatic cancer treatment

Role: Co-Investigator (10% Effort)

Grant Period: Sept. 1, 2017-Aug. 31, 2023

4. King Saudi Arabia International Collaboration Grant

Title: Genetic polymorphism of IL-6, IL-8 and CRP genes as prognostic biomarkers for chemotherapeutic response in Saudi Arabia and American ovarian patients

Role: Co-Principal Investigator

Total Cost: $75,000

Grant Period: Aug. 1, 2020-Aug. 31, 2023

5. UTHSC Seed grant

Title: α-Mangostin: A novel therapeutic agent for pancreatic cancer treatment

Role: Principal Investigator

Total Cost: $35,000

Grant Period: June 1, 2017-May 30, 2019

6. Dean Seed grant (MPI)

Title: Targeting ribosome biogenesis and tumor microenvironment for pancreatic cancer treatment

Role: Principal Investigator

Total Cost: $15,000

Grant Period: Nov. 1, 2018-Oct. 31, 2019

7. UTRF grant

Total Cost: $15,000

Role: Co-investigator

Grant Period: Jan. 1, 2019-Oct. 30, 2019

1. Hafeez B.B., Ahmad I., Haque R., Raisuddin S. Protective effect of Cassia occidentalis L. on cyclophosphamide-induced suppression of humoral immunity in mice. Journal of Ethnopharmacology 2001, 75; 13-18. PMID: 11282437.
2. Haque R., Hafeez B.B., Ahmad I., Parvez S., Pandey S., Raisuddin S. Immunomodulatory and glutathione inducing effects of Emblica officinalis Gaertn in cyclophosphamide-treated mice. Human and Experimental Toxicology 2001, 20; 643-650. PMID: 11936579.
3. Pandey S., Ahmad I., Parvez S., Hafeez B.B., Haque R., Raisuddin S. Effect of endosulfan on antioxidants of freshwater fish Channa punctatus Bloch.1. Protection against lipid peroxidation in liver by copper preexposure. Archives of Environmental Contamination and Toxicology 2001, 41; 345-352. PMID: 11503072.
4. Hafeez B.B., Haque R., Parvez S., Pandey S., Saeed I., Raisuddin S. Immunomodulatory effect of Trigonella foenum graecum in mice. International Immunopharmacology 2003, 3; 257-265. PMID: 12586606.
5. Haque R., Hafeez B.B., Parvez S., Pandey S., Saeed I., Ali M., Raisuddin S. Aqueous extract of walnut (Juglans regia L.) protects mice against cyclophosphamide induced biochemical toxicity. Human and Experimental Toxicology 2003, 22; 473-480. PMID: 14580007.
6. Sayeed I., Parvez S., Pandey S., Hafeez B.B., Haque R., Raisuddin S. Oxidative stress biomarkers of exposure to deltamethrin in freshwater fish, Channa punctatus Bloch. Ecotoxicology and Environmental Safety 2003, 56; 295-301. PMID: 12927561.
7. Parvez S., Sayeed I., Pandey S., Ahmad A., Hafeez B.B., Haque R., Raisuddin S. Modulatory effect of copper on nonenzymatic antioxidants in freshwater fish Channa punctatus Bloch. Biological Trace Element Research 2003, 93; 237-48. PMID: 12835505.
8. Pandey S., Parvez S., Sayeed I., Haque R., Hafeez B.B., Raisuddin S. Biomarkers of oxidative stress: A comparative study of river Yamuna fish Wallago attu (Bloch and Schneider). Science of the Total Environment 2003, 309:105-115. PMID: 12798096.
9. Ahmed S., Naizen W., Hafeez B.B., Haqqi T.M. Punica granatum L extracts inhibits IL-1 beta induced expression of matrix metalloproteinases by inhibiting the activation of the mitogen activated protein kinesis and Nuclear Factor-kB activity in human chondrocytes in vitro. Journal of Nutrition 2005, 135; 2096-102. PMID: 16140882.
10. Hafeez B.B., Ahmed S., Naizen W., Haqqi T.M. Green tea polyphenols-induced apoptosis in human osteosarcoma SAOS-2 cells involves a caspase-dependent mechanism with downregulation of nuclear factor-kappaB. Toxicology and Applied Pharmacology 2006, 216;11-9. PMID: 16797629.
11. Ewens A., Luo L., Berleth E., Alderfer J., Wollman R., Hafeez B.B., Kanter P., Mihich E., Ehrke M.J. Doxorubicin plus interleukin-2 chemoimmunotherapy against breast cancer in mice. Cancer Research 2006, 66; 5419-26. PMID: 16707470. IF: 12.7.
12. Saleem M., Kweon M.H., Johnson J.J., Adhami V.M., Elcheva I., Khan N., Hafeez B.B., Bhat K.M., Sarfaraz S., Reagan-Shaw S., Spiegelman V.S., Setaluri V., Mukhtar H. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proceeding of the National Academy of Sciences (PNAS) USA 2006, 103; 14825-30. PMID: 16990429. IF: 10.
13. Siddiqui I.A., Malik A., Adhami V.M., Asim M., Hafeez B.B., Sarfaraz S., Mukhtar H. Green tea polyphenols EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene 2008, 27(14):2055-63. PMID: 17998943. IF: 7.5.
14. Hafeez B.B., Imtiaz I.A., Asim M., Malik A., Afaq F., Adhami V.M., Saleem M., Mukhtar H. Delphinidin, a major anthocyanidin present in pigmented fruits and vegetables inhibits the prostate cancer cells xenograft in athymic nude mice. Cancer Research 2008, 15; 68 (20):8564-72. PMID:18922932. IF: 12.7.
15. Hafeez B.B., Asim M., Siddiqui I.A., Adhami V.A., Ahmad A., Jakka S.A., Baniahmad A. and Mukhtar H. Delphinidin, a dietary anthocyanidin in pigmented fruits and vegetables: A new weapon to blunt prostate cancer growth. Cell Cycle 2008, 7(21):3320-6. PMID: 18948740. IF: 7.7.
16. Siddiqui I.A., Shukla Y., Adhami V.M., Sarfaraz S., Asim M., Hafeez B.B., Mukhtar H. Suppression of NF-kappaB and its regulated gene products by oral administration of green tea polyphenols in an autochthonous mouse prostate cancer model. Pharmaceutical Research 2008,25(9): 2135-42. PMID: 18317887.
17. Asim M., Siddiqui I.A., Hafeez B.B., Baniahmad A., Mukhtar H. Src Kinase potentiates androgen receptor transactivation function and invasion of androgen-independent prostate cancer C4-2 cells. Oncogene 2008, 27(25):3596-604. 27(14):2055-63. PMID: 18223692. IF: 7.5.
18. Saleem M., Maddodi N., Zaid M.A., Khan N., Hafeez B.B., Asim M., Suh Y., Yun J., Setaluri V., Mukhtar H. Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis. Clinical Cancer Research 2008, 14: 2119-27. PMID: 18381953. IF: 10.4.
19. Aziz M.H., Hafeez B.B., Sand J.M., Pierce D.B., Aziz S.W., Dreckschmidt N.E. and Verma A.K. Protein kinase C epsilon mediates Stat3Ser727 phosphorylation, Stat3-regulated gene expression and cell invasion in various human cancer cell lines via integration with ERK1/2. Oncogene 2009; 27;29(21):3100-9. IF: 7.5.
20. Murtaza I., Adhami V.M., Hafeez B.B., Saleem M. and Mukhtar H. Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3 mediated inhibition of NF-κB. International Journal of Cancer 2009, 125(10):2465-73. PMID: 19670328. IF: 7.5.
21. Murtaza I., Saleem M., Adhami V., Hafeez B.B., Mukhtar H. Suppression of cFLIP by Lupeol a dietary triterpene is sufficient to overcome resistance to TRAIL-mediated apoptosis in chemoresistant human pancreatic cancer cells. Cancer Research 2009, 69(3):1156-65. PMID: 19176377. IF: 12.5.
22. Hafeez B.B., Adhami V.M., Asim M., Imtiaz I.A., Saleem M., Kumar M.R. Bhat, Din M., Sataluri V.S., Mukhtar H. Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cell concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator. Clinical Cancer Research 2009, 15(2);452-9. PMID: 19147749. IF: 10.5.
23. Siddiqui I.A., Adhami V.M., Bharali D.J., Hafeez B.B., Asim M., Khwaja S.I., Ahmad N., Cui H., Mousa S.A., Mukhtar H. (2009). Introducing nanochemoprevention as a novel approach for cancer control: Proof of principle with green tea polyphenol Epigallocatechin-3-Gallate. Cancer Research 2009, 69(5);1712-6. PMID: 19223530. IF: 10.5.
24. Adhami V.M., Siddiqui I.A., Sarfaraz S., Khwaja S.I., Hafeez B.B., Ahmad N., Mukhtar H. Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease. Clinical Cancer Research 2009, 15(6);1947-53. PMID: 19276266. IF: 10.5.
25. Saleem M., Murtaza I., Tarapore R., Suh Y., Adhami V.M., Johnson J.J., Siddiqui I.A., Khan N., Asim M., Hafeez B.B., Shekhani M.T., Li B., Mukhtar H. Lupeol inhibits proliferation of human prostate cancer cells by targeting {beta}-catenin signaling. Carcinogenesis 2009, 30(5);808-17. PMID: 19233958.
26. Siddiqui I.A., Asim M., Hafeez B.B., Adhami V.M., Tarapore R.S., Mukhtar H. Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer. FASEB J 2011, 25(4);1198-207. PMID: 21177307.
27. Prasad A.S., Mukhtar H., Beck F.W., Adhami V.M., Siddiqui I.A., Din M., Hafeez B.B., Kucuk O. Dietary zinc and prostate cancer in the TRAMP mouse model. Journal of Medicinal Food 2010, 13(1);70-6. PMID: 20136438.
28. Hafeez B.B., Zhong, W., Weichert J., Dreckschmidt N.E., Jamal M.S., Verma A.K. Genetic ablation of PKC epsilon inhibits prostate cancer development and metastasis in transgenic mouse model of prostate adenocarcinoma. Cancer Research 2011, 71(6);2318-27. PMID: 21406403. IF: 12.5.
29. Asim M., Hafeez B.B., Siddiqui I.A., Gerlach C., Patz M., Mukhtar H., Baniahmad A. LCoR acts as a novel androgen receptor corepressor inhibits prostate cancer growth, and its functionality is inactivated by the Src kinase. Journal of Biological Chemistry 2011, 6 (43):37108-17. PMID: 2185674.
30. Sand J.M., Hafeez B.B., Aziz M.H., Seibers E.M., Verma A.K. Ultraviolet radiation and 12-O- tetradecanoylphorbol-13-acetate-induced interaction of mouse epidermal protein kinase C ε with Stat3 involve integration with ERK1/2. Molecular Carcinogenesis 2012. April;51(4):291-302.PMID: 21480396.
31. Sand J.M., Hafeez B.B., Jamal M.S., Witkowsky O., Siebers E.M., Fischer J., Verma A.K. Carcinogenesis 2012, 33(1):184-90. PMID: 22072620.
32. *Hafeez B.B., Jamal S., Fischer J., Mustafa A., Verma A.K. Plumbagin, a plant based napthoquinone inhibits the growth of pancreatic cancer cells in vitro and in vivo via targeting EGFR, Stat3 and NF- kB signaling networks. International Journal of Cancer 2012,131(9):2175-86. PMID:22322442. (*Corresponding author). IF: 7.5.
33. *Hafeez B.B., Fischer J., Jamal S., Mustafa A., Verma A.K. Plumbagin inhibits prostate cancer development in TRAMP mice via targeting PKCε, Stat3 and neuroendocrine markers. Carcinogenesis 2012, 33(12):2586-92. PMID: 22976928. (*Corresponding author).
34. *Hafeez B.B., Zhong W., Fischer J.W., Mustafa A., Shi X., Meske L., Hong H., Cai W., Havighurst T., Kim K., Verma A.K. Plumbagin inhibits human prostate cancer PC3M luciferase cells derived xenograft tumors and metastasis in an orthotropic xenograft mouse model. Molecular Oncology 2013, 7(3):428-39. PMID:23273564 (*Corresponding author). IF: 7.5.
35. *Hafeez B.B., Mustafa A., Fischer J.W., Singh A., Zhong W., Sheikhani M.O., Meske L., Havighurst T., Kim K., Verma A.K. α-Mangostin, a dietary antioxidant inhibits the growth of pancreatic cancer cells xenograft tumors in athymic nude mice. Anti-oxidant and Redox Signaling Aug. 10, 2013;21(5):682-99. PMID:24295217 (*Corresponding author). IF: 6.0.
36. Singh A., Sand J.M., Heninger E., Hafeez B.B., Verma A.K. Protein Kinase Cε, which is linked to ultraviolet radiation-induced development of squamous cell carcinomas, stimulates rapid turnover of adult hair follicle stem cells. Journal of Skin Cancer 2013, 2013:452425. PMID: 23738074.
37. Singh A., Bauer S., Singh A., Sand J.M, Hafeez B.B., Meske L. and Verma A.K. Topically applied Hsp90 inhibitor 17AAG inhibits ultraviolet radiation-induced cutaneous wrinkles and squamous cell carcinomas. Journal of Investigative Dermatology, Oct. 22, 2014 (Epub ahead of print). PMID:25337691.
38. *Hafeez B.B., Fischer J.W., Singh A., Zhong W., Mustafa A., Meske L., Sheikhani M.O., Verma A.K.. Cancer Prevention Research. 2015 May;8(5):375-86. PMID:25627799. (*Corresponding author).
39. Singh A., Willems E., Singh A., Hafeez B.B., Ong I.M., Mehta S.L., Verma A.K. Ultraviolet radiation-induced tumor necrosis factor alpha, which is linked to the development of cutaneous SCC, modulates differential epidermal microRNAs expression. Oncotarget. April 5, 2016; 7(14):17945-56. PMID: 2691845.
40. Hafeez B.B., Meske L., Singh A., Zhong W., Powers P.,John M., Griep A.E., Verma A.K. Oncotarget. May 31, 2016; 7(22):33069-80. PMID: 27102301.
41. Nagesh P.K.B., Johnson N.R., Boya V.K.N., Chowdhury P., Othman S.F., Khalilzad-Sharghi V., Hafeez B.B., Ganju A., Khan S., Behrman S.W., Zafar N., Chauhan S.C., Jaggi M., Yallapu M.M. PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer. Colloids and Surfaces B: Biointerfaces Aug. 1, 2016; 144:8-20. PMID:2705827.
42. Khan S., Sikander M., Ebeling M.C., Ganju A., Kumari S., Yallapu M.M., Hafeez B.B., Ise T., Nagata S., Zafar N., Behrman S.W., Wan J.Y., Ghimire H.M., Sahay P., Pradhan P., Chauhan S.C., Jaggi M. Oncogene. Jan. 26, 2016; 36(4):491-500. PMID:27321183. IF: 7.5.
43. Sikander M.,* Hafeez B.B., Malik S., Alsayari A., Halaweish F.T., Yallapu M.M., Chauhan S.C., Jaggi M. Cucurbitacin D exhibits potent anticancer activity in cervical cancer. Scientific Reports. Nov. 8, 2016; 6:36594. PMID: 27824155. (*Co- first author).
44. Ganju A., Khan S., Hafeez B.B., Behrman S.W., Yallapu M.M., Chauhan S.C., Jaggi M. Drug Discovery Today. 2017 February; 22(2):424-432. PMID: 27815139.
45. Chowdhury P., Roberts A.M., Khan S., Hafeez B.B., Chauhan S.C., Jaggi M., Yallapu M.M. Drug Discovery Today. 2017 August;22(8):1233-1241. PMID: 28526660.
46. Hafeez B.B., Ganju A., Sikander M., Kashyap V.K., Chauhan N., Malik S., Massey A.E., Tripathi M.K., Halaweish F.T., Zafar N., Singh M.M., Yallapu M.Y., Chauhan S.C., Jaggi M. Ormeloxifene suppresses prostate tumor growth and metastatic phenotypes via inhibition of oncogenic β-catenin signaling and EMT progression. Molecular Cancer Therapeutics 2017 October;16(10):2267-2280. PMID: 28615299.
47. Chowdhury P., Prashanth K.B., Nagesh, Sheema Khan, Hafeez B.B., Chauhan S.C., Jaggi M., Yallapu M.M. Development of polyvinylpyrrolidone/paclitaxel self-assemblies for breast cancer. Acta Pharmaceutica Sinica B, 2018 July;8(4):602-614. PMID: 30109184.
48. Ganju A., Chauhan S.C., Hafeez B.B., Doxtater K., Tripathi M.K., Zafar N., Yallapu M.M., Kumar R., Jaggi M. Protein kinase D1 regulates subcellular localization and metastatic function of metastasis-associated protein 1. British Journal of Cancer. Feb. 20, 2018; 118(4):587-599. PMID: 29465084.
49. Nagesh P.K.B., Hatami E., Chowdhury P., Kashyap V.K., Khan S., Hafeez B.B., Chauhan S.C., Jaggi M., Yallapu M.M. Cancers (Basel). March 7, 2018; 10(3):68. PMID: 29518944.
50. Nagesh P.K.B., Chowdhury P., Hatami E., Boya V.K.N., Kashyap V.K., Khan S., Hafeez B.B., Chauhan S.C., Jaggi M., Yallapu M.M. . Cancers (Basel). Aug. 25, 2018; 10(9).
51. Kashyap V.K., Wang Q., Setua S., Nagesh P.K.B., Chauhan N., Kumari S., Chaudhury P., Miller D.D., Yallapu M.M., Li W., Jaggi M., *Hafeez B.B., Chauhan S.C*. Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer. Journal of Experimental and Clinical Cancer Research 2019 38:29. PMID: 30674344. (*Co-corresponding author). IF:11.4.
52. Messy A., Sikander M., Chauhan N., Kumari S., Setua S., Shetty A.B., Mandil H., Kashyap V.K., Khan S., Jaggi M., Yallapu M.M., *Hafeez B.B., Chauhan S.C. Next-generation Paclitaxel-nanoparticle formulation for pancreatic cancer treatment. Nanomedicine. June 4, 2019; 20:102027. PMID 31170509. (*Co-first author).
53. Chauhan N., Maher D.M., Hafeez B.B., Mandil H., Singh M.M., Yallapu M.M., Jaggi M., Chauhan S.C. International Journal of Nanomedicine. Sept. 3, 2019; 14:7107-7121. PMID:31564868.
54. Chauhan N., Maher D.M., Yallapu M.M., Hafeez B.B., Singh M.M., Chauhan S.C., Jaggi M. Scientific Reports. July 29, 2019; 9(1):10917. PMID: 31358785.
55. Khan S., Setua S., Kumari S., Dan N., Massey A., Hafeez B.B., Yallapu M.M., Stiles Z.E., Alabkaa A., Yue J., Ganju A., Behrman S., Jaggi M., Chauhan S.C. Biomaterials. 2019 July;208:83-97. PMID: 30999154.
56. Shetty A., Nagesh P.K.B., Setua S., Hafeez B.B., Jaggi M., Yallapu M.M., Chauhan S.C. Novel paclitaxel nanoformulation impairs de novo lipid synthesis in pancreatic cancer cells and enhances gemcitabine efficacy. ACS Omega. April 13, 2020; 5(15):8982-8991.
57. Massey A.E., Malik S., Sikander M., Doxtater K.A., Tripathi M.K., Yallapu M.M., Jaggi M., Chauhan S.C., Hafeez B.B.* Clinical implications of exosomes: Targeted drug delivery for cancer treatment. International Journal of Molecular Sciences May 17, 2021; 22(10):5278). PMID: 34067896. (*Corresponding author).
58. Kumari S., Sikander M., Malik S., Tripathi M.K., Hafeez B.B., Yallapu M.M., Chauhan S.C., Khan S., Jaggi M. Steviol represses glucose metabolism and translation initiation in pancreatic cancer cells. Biomedicines Dec. 2, 2021; 9(12):1814. PMID:34944630.
59. Haque A., Baig G.A., Alshawli A.S., Sait K.H.W., Hafeez B.B., Tripathi M.K., Alghamdi B.S., Mohammed Ali H.S.H., Rasool M. Interaction analysis of MRP1 with anticancer drugs used in ovarian cancer: In silico approach. Life (Basel) March 7, 2022; 12(3):383. PMID:35330134.
60. Chaib M., *Hafeez B.B., Mandil H., Deidre, Pingili A.K., Sikander M., Kashyap V.K., Tripathi M.K., Khan S., Behrman S., Yallapu M.M., Jaggi M., Makowski L. and Chauhan S.C. Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore. Commun Biol. Nov. 4, 2022; 5(1):1181. PMID: 36333531. (Hafeez B.B. and Chauhan S.C. are corresponding authors).
61. Haque A., Baig G.A., Alshawli A.S., Sait K.H.W., Hafeez B.B., Tripathi M.K., Alghamdi B.S., Mohammed Ali H.S.H., Rasool M. Interaction analysis of MRP1 with anticancer drugs used in ovarian cancer: In silico approach. Life (Basel). March 7, 2022; 12(3):383.
62. Ahmad M., Dhasmana A., Harne P.S., Zamir A., Hafeez B.B.* Chemokine clouding and liver cancer heterogeneity: Does it impact clinical outcomes? Seminars in Cancer Biology 2022 November;86(Pt 3):1175-1185. PMID: 35189322. (*Corresponding author).
63. Hafeez B.B., Alvarado E.W., Kim D.J. Photochem Photobiol. 2023 March;99(2):874-877. PMID: 36151964.
64. Asare O., Ayala Y., Hafeez B.B., Ramirez-Correa G.A., Cho Y.Y., Kim D.J. Photochem Photobiol. 2023 March;99(2):344-355. PMID: 36029171.
65. Doxtater K., Tripathi M.K., Sekhri R., Hafeez B.B., Khan S., Zafar N., Yallapu M.M., Jaggi M. and Chauhan S.C. MUC13 drives cancer aggressiveness and metastasis through the YAP1-dependent pathway. Life Science Alliance (EMBO), Oct. 4, 2023; 6(12): e202301975. PMID:37793774.
66. Asif M., Alvi S.S., Azaz T., Khan A.R., Tiwari B., Hafeez B.B.,* Nasibullah M.* Novel functionalized Spiro [Indoline-3,5'-pyrroline]-2,2'dione derivatives: Synthesis, characterization, drug-likeness, ADME and anticancer potential. International Journal of Molecular Sciences April 15, 2023; 24(8):7336. PMID:37108498. (Hafeez B.B.* and Nasibullah M.* are corresponding authors).
67. Setua S., Shabir S., Shaji P., Bulnes A.M., Dhasmana A., Holla S., Mittal N.K., Sahoo N., Saini T., Giorgianni F., Sikander M., Massey A.E., Hafeez B.B., Tripathi M., Diego V., Jaggi M., Yu J., Zafar N., Yallapu M.M., Behrman S.W., Khan S., Chauhan S.C. Exosome derived from tumor adjacent fibroblasts efficiently target pancreatic cancer. Acta Pharmaceutica Sinica B 2024 July;14(7):3009-3026. PMID: 39027237.
68. Bangash A., Alvi S., Bangash M., Ehsan H., Ahmad M., Bansal D., Khan S., Shareef R., Chauhan S.C., *Hafeez B.B. Honey targets ribosome biogenesis components to suppress the growth of human pancreatic cancer cells. Cancers (Basel). Oct. 9, 2024;16(19):3431. PMID: 39410048 (*Corresponding author).
69. Kashyap V.K., Nagesh P.K.B., Singh A.K., Massey A., Darkwah G.P., George A., Khan S., Hafeez B.B., Zafar N., Kumar S., Sinha N., Yallapu M.M., Chauhan N., Chauhan S.C. Curcumin attenuates smoking and drinking activated NF-κB/IL-6 inflammatory signaling axis in cervical cancer. Cancer Cell International Oct. 20, 2024; 24(1):343. PMID: 39428480.
70. Asare O., Shim L., Lee C., Delgado J., Quales N., Zavala K., Park J., Hafeez B.B., Cho Y., Chauhan S.C., Kim D.J. Loss of TC-PTP in keratinocytes leads to increased UVB-induced autophagy. Cell Death Discovery Feb. 28, 2025; 11(1):80. PMID: 40021617.
71. Ahmad M., Alvi S.S., Ahsan H., Perez C., Massey A., Kashyap V.K., Chauhan N., Anning E., Bangash A., Tripathi M., Kim D.J., Sahoo N., Khan M., Chauhan S.C., *Hafeez B.B. Ubiquitination of oncogenic mutant p53 via attenuation of ribosome biogenesis machinery effectively inhibits pancreatic tumor growth. Molecular Cancer Therapeutics, Feb. 4, 2026; 25(2):257-271. PMID: 41053975.
72. Ahmad M., Alvi S.S., Dhasmana A., Kim D.J., Yallapu M.M., Chauhan S.C., *Hafeez B.B. Mitochondrial ribosomal protein MRPL3: An early diagnostic biomarker and possible molecular target in pancreatic cancer. Translational Oncology May 29;58:102432, 2025. PMID: 40446627.
73. Autoinhibitory feedback regulation of RNA polymerase I catalytic subunit RPA194 controls its gene expression. Ahmad M., Alvi S.S., Kim D.J., Chauhan S.C., *Hafeez B.B. Journal of Biological Chemistry 2025 (Under revision).